Organon & Co. Shares Issued
Organon & Co. (OGN) had Shares Issued of 262.61 million shares as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-07-31
- 2026-06-30: Common Stock, Shares, Issued 262.61M shares.
- 2026-03-31: Common Stock, Shares, Issued 262.65M shares.
- 2025-12-31: Common Stock, Shares, Issued 260.32M shares.
- 2025-09-30: Common Stock, Shares, Issued 259.98M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 262.61M shares 10-Q · filed 2026-07-31 | |
| 2026-03-31 | 262.65M shares 10-Q · filed 2026-05-04 | |
| 2025-12-31 | 260.32M shares 10-Q · filed 2026-07-31 | |
| 2025-09-30 | 259.98M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 259.96M shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 257.95M shares 10-Q · filed 2025-05-02 | |
| 2024-12-31 | 257.80M shares 10-K · filed 2026-02-24 | |
| 2024-09-30 | 257.54M shares 10-Q · filed 2024-11-01 | |
| 2024-06-30 | 257.47M shares 10-Q · filed 2024-08-07 | |
| 2024-03-31 | 255.85M shares 10-Q · filed 2024-05-03 | |
| 2023-12-31 | 255.63M shares 10-K/A · filed 2025-11-10 | |
| 2023-09-30 | 255.61M shares 10-Q · filed 2023-11-03 | |
| 2023-06-30 | 255.57M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 254.43M shares 10-Q · filed 2023-05-05 | |
| 2022-12-31 | 254.37M shares 10-K · filed 2024-02-26 | |
| 2022-09-30 | 254.36M shares 10-Q · filed 2022-11-04 | |
| 2022-06-30 | 254.32M shares 10-Q · filed 2022-08-05 | |
| 2022-03-31 | 253.64M shares 10-Q · filed 2022-05-06 | |
| 2021-12-31 | 253.55M shares 10-K · filed 2023-02-27 | 253.55M shares 10-K · filed 2022-03-21 |
| 2021-09-30 | 253.55M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 253.52M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |